JOSEPH SOUTHERN: Open Payments
NPI 1528667995 · SHEFFIELD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 28 payments from 8 companies in 2025. Trend: 2023 $119 · 2024 $514 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $183 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Corcept Therapeutics | 2 | $39 |
| ABBVIE INC. | 2 | $33 |
| PFIZER INC. | 2 | $32 |
| Lundbeck LLC | 2 | $31 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $29 |
| Dexcom, Inc. | 1 | $16 |
Products named: Ozempic, Wegovy, Korlym, BREZTRI, NURTEC ODT, VYEPTI, CAPLYTA, VRAYLAR.
Industry payments across AL — which companies pay providers there.
